4//SEC Filing
INFINITY PHARMACEUTICALS, INC. 4
Accession 0001209191-15-037973
CIK 0001113148operating
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:42 PM ET
Size
8.0 KB
Accession
0001209191-15-037973
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-04-30−4,737→ 0 totalExercise: $2.04From: 2005-05-10Exp: 2015-05-10→ Common Stock (4,737 underlying) - Exercise/Conversion
Common Stock
2015-04-30$2.04/sh+4,737$9,663→ 5,605 total
Holdings
- 6,741.146(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]This stock option was granted under the issuer's Pre-Merger Stock Incentive Plan, which permits the early exercise of unvested stock options in exchange for shares of restricted stock that are subject to a right of repurchase by the issuer that lapses in accordance with the vesting schedule of the original option. This option is fully vested.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001113148
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:42 PM ET
- Size
- 8.0 KB